HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
17-β-Hydroxyestr-4-en-3-on-17-(3-phenylpropionat)
NANDROLONE PHENPROPIONATE · Durabolin · NTPP · 19Ntpp · Activin · Durabol · Nerobil · SK 22271

Identifikatoren & physikalische Daten
| CAS No. | 114949-22-3 |
|---|---|
| Summenformel | C27H34O3 |
| Durchschnittliche Molmasse | 406,6 g/mol |
| Monoisotopische Masse | 406,25079495 g/mol |
| SMILES | C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2OC(=O)CCc1ccccc1 |
| InChIKey | UBWXUGDQUBIEIZ-QNTYDACNSA-N |
| PubChem CID | 229455 |
| ChEMBL | CHEMBL1200412 |
| ChEBI | CHEBI:7468 |
| EC No. | 200-551-9 |
| DTXSID | DTXSID2023353 |
| Lokaler Name | 17-β-Hydroxyestr-4-en-3-on-17-(3-phenylpropionat) |
Chemische & physikalische Eigenschaften
| XLogP | 5,1 |
|---|---|
| Polarare Oberfläche (TPSA) | 43,4 |
| H-Brücken-Donoren | 0 |
| H-Brücken-Akzeptoren | 3 |
| Frei drehbare Bindungen | 5 |
| Schwere Atome | 30 |
| Formalladung | 0 |
| Komplexität | 703 |
| Arzneimittel | Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive CompoundsPharmaceuticals -> Listed in ZINC15 |
| LogP (Verteilungskoeffizient) | 2.62 |
| Löslichkeit | 4.58e-04 g/LDMSO : 100 mg/mL (245.97 mMNeed ultrasonic) |
| Human Drugs | FDA approved drugs -> Active ingredientPharmaceuticals |
| Endocrine Disruptors | Potential endocrine disrupting compound |
| Schmelzpunkt | 118 °C85-87°C |
| Physical Description | Solid |
| Siedepunkt | 487.61°C (rough estimate) |
| Dichte | 1.0140 (rough estimate) |
| Brechungsindex | 1.5460 (estimate) |
| Lagerbedingungen | Controlled Substance, -20°C Freezer |
| Aggregatzustand | Solid |
| Farbe | White to Off-White |
| InChIKey | UBWXUGDQUBIEIZ-QNTYDACNSA-N |
| SMILES | C[C@]12CC[C@]3([H])[C@@]4([H])CCC(=O)C=C4CC[C@@]3([H])[C@]1([H])CC[C@@H]2OC(=O)CCC1C=CC=CC=1 |&1:1,4,6,16,18,22,r| |
| CAS Datenbank | 62-90-8(CAS DataBase Reference) |
| NIST chemische Informationen | 4-Androstene-17-beta-ol-3-one, 19-nor-delta-, phenylpropionate(62-90-8) |
Sicherheit & Vorschriften
| GHS-Einstufung | DangerH302 (98.2%): Harmful if swallowed [Warning Acute toxicity, oral]P203, P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P318, P321, P330, P362+P364, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 57 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| Regulatorische Informationen | Nandrolone phenylproprionate: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right. |
| Weitere Sicherheitsinformationen | IMAP assessments - Estr-4-en-3-one, 17-(1-oxo-3-phenylpropoxy)-, (17.beta.)-: Environment tier I assessment |
| Hazard Classes and Categories | Acute Tox. 4 (98.2%) |
| Drug Induced Liver Injury | Drug Induced Liver Injury Rank (DILIrank 2.0)Nandrolone phenpropionatevMost-DILI-concern7Warnings & precautionsDOI:10.1016/j.drudis.2016.02.015 |
| Wassergefährdungsklasse (WGK) | WGK 3 |
| RTECS-Nr. | KG7995000 |
| R-Sätze (R) | 20/21/22-40 |
| Toxizität | LD50 intraperitoneal in mouse: > 1gm/kg |
| Gefahrensymbole | Xn |
| Sicherheitshinweise (S) | 23-36 |
| Lagerklasse | 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects |
| Gefahrenklasse | Carc. 2Repr. 1B |
Anwendungen & Verwendung
Verwenden
Anabolic steroid; androgen.